Zaneta Odrowaz
InvestorFounderVice President of Company Creation at Frazier Life Sciences · Founder at Attovia Therapeutics
Palo Alto
FoundedAttovia Therapeutics
Find your path to Zaneta
1,797 people in our graph share verified history with Zaneta — schools, employers, funds. One of them is your warm intro.
About
Zaneta Odrowaz joined Frazier Life Sciences in 2022 as a Vice President focused on company creation, and co-founded Attovia Therapeutics, where she serves as Chief Business Officer. She previously was Senior Director of Corporate Development at Amunix Pharmaceuticals, contributing to its acquisition by Sanofi, and earlier held roles as Chief of Staff at Philips Neuro and Engagement Manager at McKinsey. She holds a Ph.D. in Gene Expression from The University of Manchester and a Master's in Biotechnology from Jagiellonian University, and completed a postdoctoral fellowship at Stanford University.
Invests in
Biotech
Founder at Attovia Therapeutics
Intro paths
In turn, Zaneta can intro founders to Attovia Therapeutics's investors below.
Attovia Therapeutics's investors · 7
Co-founders at Attovia Therapeutics
Experience
- Attovia TherapeuticsChief Business Officercurrent2023 — present
- Frazier Life SciencesVP Company Creationcurrent2022 — present
- Amunix PharmaceuticalsSenior Director Corporate Development2020 — 2022
- Philips NeuroChief Of Staff2018 — 2020Pleasanton, CA
- McKinsey & CompanyEngagement Manager2015 — 2018
- Oxbridge Biotech RoundtableProject Manager2014 — 2015
- Stanford UniversityPostdoctoral Fellow2012 — 2015Stanford, CA
Skills & more
+12 more
ImmunohistochemistryImmunoprecipitationqPCRTransfectionFlow CytometryCell CultureImmunofluorescenceProtein PurificationStrategyRNA isolationDNART-PCRLanguages English · Italian · Polish
From Zaneta's professional profile.
Investments
Investor
Per the firm's website.
Colleagues at Frazier Life Sciences
Frequently asked questions
- Who is Zaneta Odrowaz?
- Zaneta Odrowaz joined Frazier Life Sciences in 2022 as a Vice President focused on company creation, and co-founded Attovia Therapeutics, where she serves as Chief Business Officer. She previously was Senior Director of Corporate Development at Amunix Pharmaceuticals, contributing to its acquisition by Sanofi, and earlier held roles as Chief of Staff at Philips Neuro and Engagement Manager at McKinsey. She holds a Ph.D. in Gene Expression from The University of Manchester and a Master's in Biotechnology from Jagiellonian University, and completed a postdoctoral fellowship at Stanford University.
- Where does Zaneta Odrowaz work?
- Zaneta Odrowaz is Founder of Attovia Therapeutics and Vice President of Company Creation at Frazier Life Sciences.
- What does Zaneta Odrowaz invest in?
- Zaneta Odrowaz invests in Biotech.
- What companies did Zaneta Odrowaz found?
- Zaneta Odrowaz founded Attovia Therapeutics.
- What companies has Zaneta Odrowaz invested in?
- Investments tracked here include Attovia Therapeutics.
- Where did Zaneta Odrowaz go to school?
- Zaneta Odrowaz studied at The University of Manchester (Doctor of Philosophy (PhD), Gene expression); Jagiellonian University (Masters, Biotechnology).
Founder mafias
Stanford University mafia1,934
Also came through, then founded or led a company.
+ 1,927 more
McKinsey & Company mafia736
Also came through, then founded or led a company.
+ 729 more
The University of Manchester mafia104
Also came through, then founded or led a company.
+ 97 more
Frazier Life Sciences mafia14
Also came through, then founded or led a company.
+ 7 more
Jagiellonian University mafia7
Also came through, then founded or led a company.
Same school
Also attended The University of Manchester343
+ 337 more
Also attended Jagiellonian University34
+ 28 more
Shared employers
Also worked at Attovia Therapeutics5
Also worked at McKinsey & Company2,000
+ 1,994 more
Also worked at Oxbridge Biotech Roundtable10
+ 4 more
Also worked at Stanford University1,149
+ 1,143 more








































































